C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
VRNOF Equity

VRNOF

OTCMKTS · VRNOF

$1.32
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
53/100 composite
Fundamentals70
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

The CIN framework assigns Verano Holdings a Neutral rating at 53/100, with conviction of 2 out of 5. Fundamentals carry 35 percent of the model, regulatory posture 25, market signal 25, and editorial density 15, with every pillar contribution auditable. Fundamentals leads the pillar table at 70, and is the main lever behind the Neutral conclusion. The offset comes from editorial at 30, which pulls the composite toward the middle of the band.

Under the hood, the data points sit as follows: reported revenue growth of -6.4 percent year over year, an operating margin of 7.2 percent, a market cap near 427 million. Each of those figures ties back to a specific input in the pillar breakdown. All inputs are drawn from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage density. Because every ticker in the CIN universe is scored on the same 336-name basis, Verano Holdings slots into a direct comparison rather than a bespoke narrative, and the score refreshes on the primary-source ingest cadence.

The clearest catalyst is the next quarterly print. Fundamentals contribute 70 of the composite, and either an acceleration in top-line growth or a stabilization of the operating margin would move the score higher; a deterioration on either would compress it.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
CEO
George Archos
CFO
Rich Tarapchak
SEC CIK
0001848416
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$426.9M
Enterprise value
$904.6M
Price to book
0.54
Price to sales
0.41
EV / EBITDA
6.44
Revenue (TTM)
$833.1M
Gross profit (TTM)
$419.2M
EBITDA
$210.3M
Operating margin
7.2%
Profit margin
-41.7%
Rev growth YoY
-6.4%
Return on equity
-33.0%
Return on assets
2.5%
EPS (TTM)
$-0.99
EPS est. current year
$-0.26
Wall St. target price
$5.00
Shares outstanding
361.8M
Insider ownership
13.4%
Institutional ownership
10.2%
Beta
1.67
Full-time employees
3,800
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for VRNOF (VRNOF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for VRNOF (VRNOF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Bullish and bearish analyst opinions for Verano Holdings (VRNOF)

Bullish view. Verano Holdings is a top-tier US MSO with market-leading positions in Florida, New Jersey, and Illinois, plus a maturing Ohio adult-use footprint; bulls model operating-margin expansion as flagship states scale and note the brand portfolio (Zen Leaf retail, Encore concentrates, MUV medical) drives premium price capture that peers struggle to match.

Bearish view. Bearish views cite Florida adult-use referendum uncertainty, 280E cash-tax drag that limits reinvestment capacity, and MSO multiple compression that has held the whole peer group at deep discounts to consumer-staples benchmarks.

Live ratings, price targets, and consensus figures for Verano Holdings appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for VRNOF are maintained by Cannabis Investor News and refreshed throughout the trading day.